Testing effectiveness (Phase 2)Ended earlyNCT02649751
What this trial is testing
Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Who this might be right for
Cystic Fibrosis
University Hospital, Brest 49